n.a. (TKMR)

4.02
0.08 1.95
NASDAQ
Prev Close 4.10
Open 4.22
Day Low/High 3.98 / 4.33
52 Wk Low/High 4.01 / 26.73
Volume 346.21K
Exchange NASDAQ
P/E Ratio N/A
Div & Yield N.A. (N.A)
Tekmira Provides Update On Licensed Product Candidate, Marqibo(R)

Tekmira Provides Update On Licensed Product Candidate, Marqibo(R)

Talon Therapeutics' Marqibo Granted Accelerated Approval by FDA Triggering Milestone Payment to Tekmira

Biotech Stock Mailbag: NuPathe

Biotech Stock Mailbag: NuPathe

Biotech columnist Adam Feuerstein answers readers' questions and concerns about health care and drug-related stocks.

Tekmira Provides Corporate Update And Reports 2010 Audited Results

Tekmira Provides Corporate Update And Reports 2010 Audited Results

Conference Call at 12 noon Eastern Time Today